530313
KIMIABL
Start SIP
Invest Now
Start SIP in KIMIABL
Performance
- Low
- ₹31
- High
- ₹33
- 52 Week Low
- ₹26
- 52 Week High
- ₹87
- Open Price₹33
- Previous Close₹33
- Volume2,189
Investment Returns
- Over 1 Month + 4.15%
- Over 3 Month -15.6%
- Over 6 Month -49.97%
- Over 1 Year -31.96%
Smart Investing Starts Here Start SIP with Kimia Biosciences for Steady Growth!
Kimia Biosciences Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 17.7
- PEG Ratio
- 0.1
- Market Cap Cr
- 145
- P/B Ratio
- 12.5
- Average True Range
- 2.33
- EPS
- -
- Dividend Yield
- 0
- MACD Signal
- -0.26
- RSI
- 47.41
- MFI
- 56.67
Kimia Biosciences Financials
Kimia Biosciences Technicals
EMA & SMA
Current Price
₹30.62
-2
(-6.13%)
- Bearish Moving Average 15
- Bullish Moving Average 1
- 20 Day
- ₹31.27
- 50 Day
- ₹32.62
- 100 Day
- ₹36.15
- 200 Day
- ₹40.28
Resistance and Support
31.3
- R3 34.19
- R2 33.39
- R1 32.10
- S1 30.01
- S2 29.21
- S3 27.92
Kimia Biosciences Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2025-11-14 | Quarterly Results | |
| 2025-09-04 | Final Dividend & A.G.M. | |
| 2025-08-29 | A.G.M. & Others | Inter-alia, to consider 1. Appointment of Neeraj Arora & Associates, Chartered Accountants as Statutory Auditors for 5 years. 2. Re-appointment of Mr. Sameer Goel. 3. Other business matters. |
| 2025-08-14 | Quarterly Results | |
| 2025-05-26 | Audited Results |
Kimia Biosciences F&O
About Kimia Biosciences
- NSE Symbol
- KIMIABL
- BSE Symbol
- 530313
- Chairman & Managing Director
- Mr. Sameer Goel
- ISIN
- INE285U01025
Similar Stocks to Kimia Biosciences
Kimia Biosciences FAQs
Kimia Biosciences share price is ₹30 As on 29 December, 2025 | 07:55
The Market Cap of Kimia Biosciences is ₹144.9 Cr As on 29 December, 2025 | 07:55
The P/E ratio of Kimia Biosciences is 17.7 As on 29 December, 2025 | 07:55
The PB ratio of Kimia Biosciences is 12.5 As on 29 December, 2025 | 07:55
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.